# Cannabis Use and Mental Health in Young Canadian Adults: What a New Survey Found > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/canadian-young-adults-cannabis-mental-health-survey/ > **Published:** 2026-09-07T22:00:34-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:18-04:00 > **Clinical Summary:** cannabis mental health young adults: A new analysis of 1,240 Canadian adults aged 20 to 24 found that non-medical cannabis use was associated with greater od... --- CED Clinical Relevance #74 Notable Clinical Interest A newly published, cannabis-specific analysis of 1,240 young adults reports frequency-graded associations with poorer self-reported mental health, while its cross-sectional design prevents causal conclusions. Clinical Insight | CED Clinic A new analysis of 1,240 Canadian adults aged 20 to 24 found that non-medical cannabis use was associated with greater odds of poorer self-reported mental health. The association was larger among respondents reporting more frequent use. Because the survey was cross-sectional, it cannot establish whether cannabis use contributed to poorer mental health, poorer mental health contributed to use, or other factors influenced both. The study supports careful screening and thoughtful follow-up, not individualized prediction or diagnosis. CannabisMental HealthYoung AdultsCanadian SurveyPublic Health AudiencePatients, caregivers, clinicians, and cannabis-science readers interested in young-adult cannabis use and mental health Primary Topicnon-medical cannabis use and self-reported mental health among Canadian adults aged 20 to 24 Source[Read the full source](https://doi.org/10.1177/21676968261486895) A new analysis of 1,240 Canadian adults aged 20 to 24 found that non-medical cannabis use was associated with greater odds of poorer self-reported mental health. The association was larger among respondents reporting more frequent use. Because the survey was cross-sectional, it cannot establish whether cannabis use contributed to poorer mental health, poorer mental health contributed to use, or other factors influenced both. What This Study Teaches Us The 2024 Canadian Cannabis Survey found that 48 percent of respondents in this age group reported past-year non-medical cannabis use. Poorer self-reported mental health was more likely among those reporting past-year, past-month, and daily or almost daily use, with progressively larger odds ratios across those exposure categories. Why This Matters Young adulthood is a period when both cannabis-use patterns and mental-health needs can change quickly. This study adds a current national snapshot that can support careful screening and harm-reduction conversations, but it does not identify an individual cause, diagnosis, or treatment effect. Study SnapshotStudy TypeCross-sectional analysis of the 2024 Canadian Cannabis SurveyPopulation1,240 Canadian adults aged 20 to 24ExposureSelf-reported past-year, past-month, and daily or almost daily non-medical cannabis useOutcomeSelf-reported poorer mental healthPast-Year Use48 percent reported non-medical cannabis use in the previous 12 monthsRisk Awareness79 percent believed daily or near-daily cannabis use increases mental-health riskMental Health62 percent reported favourable mental healthPast-Year AssociationOR 1.54, 95% CI 1.21 to 1.96Past-Month AssociationOR 1.69, 95% CI 1.31 to 2.19Daily or Almost Daily AssociationOR 2.01, 95% CI 1.42 to 2.85PublishedSeptember 6, 2026DOI10.1177/21676968261486895 Clinical Bottom Line More frequent non-medical cannabis use was associated with higher odds of poorer self-reported mental health in this young-adult sample. The result supports attentive screening and conversation, not a causal claim or a diagnosis for any individual. The Frequency Pattern Is the Central Finding Compared with the survey reference group, respondents reporting past-year use had 1.54 times the odds of poorer mental health, those reporting past-month use had 1.69 times the odds, and those reporting daily or almost daily use had 2.01 times the odds. This graded pattern is clinically notable, but odds ratios describe association within the analyzed survey data. They do not show that changing cannabis use alone would necessarily change a person’s mental health. Awareness and Behavior Did Not Fully Align Seventy-nine percent of respondents believed that daily or near-daily cannabis use increases the risk of mental-health problems, while 48 percent reported past-year non-medical use. Risk awareness can coexist with use. That makes nonjudgmental questions about frequency, reasons for use, perceived effects, and personal concerns more useful than assuming that general awareness automatically determines behavior. Cross-Sectional Evidence Cannot Establish Direction The study measured cannabis use and self-reported mental health within one survey analysis. It therefore cannot determine which came first or whether unmeasured factors contributed to both findings. The safest interpretation is that cannabis-use frequency can identify a group with greater reported mental-health burden. Longitudinal and intervention studies are needed to test direction, change over time, and causality. Social Context Was Also Associated With the Outcome The abstract reports lower odds of poorer mental health among respondents who were heterosexual, had higher income, had higher education, or lived in Quebec. These associations reinforce that the cannabis and mental-health relationship sits within a broader social context. They should not be converted into causal explanations or used to make assumptions about an individual respondent. How Strong Is This Evidence? The study uses a current Canadian survey and a clearly defined young-adult group of 1,240 respondents. It reports exposure-frequency categories, adjusted regression estimates, and confidence intervals rather than relying only on a general comparison. Where This Paper Deserves Skepticism The cross-sectional design supports association, not causation or temporal direction. The accessible abstract does not provide enough detail to evaluate every survey measure, model specification, missing-data decision, or additional analysis, so this report does not reconstruct those elements. What This Paper Does Not Show The study does not show that cannabis caused poorer mental health, that poorer mental health caused cannabis use, that every young adult who uses cannabis will experience harm, or that stopping cannabis would by itself resolve a mental-health problem. How This Fits With the Broader Clinical Conversation Cannabis use and mental health can influence clinical conversations even when the evidence cannot settle direction. Frequency, purpose of use, perceived benefit, unwanted effects, and changes in functioning are all relevant questions. Population-level associations are most useful when they prompt individualized assessment. They are least useful when they are turned into deterministic labels or used to dismiss a person’s own experience. Dr. Caplan’s Take *I read this as a screening signal. When non-medical cannabis use becomes frequent, it is reasonable to ask more carefully about mood, anxiety, sleep, cognition, motivation, safety, and day-to-day functioning.* *The paper does not justify blaming cannabis for every mental-health symptom. It supports a more precise conversation about timing, frequency, context, and whether the patient sees cannabis as helping, worsening, or complicating the picture.* What a Careful Reader Should Take Away A national survey found a frequency-graded association between non-medical cannabis use and poorer self-reported mental health among adults aged 20 to 24, but the cross-sectional evidence cannot determine cause or direction. Evidence Interpretation Guide Table of Contents - [How to Interpret This Non-Medical Cannabis Use And Self-Reported Mental Health Among Canadian Adults Aged 20 To 24 Evidence Without Overstating It](#How_to_Interpret_This_Non-Medical_Cannabis_Use_And_Self-Reported_Mental_Health_Among_Canadian_Adults_Aged_20_To_24_Evidence_Without_Overstating_It)[A Four-Step Reading Frame](#A_Four-Step_Reading_Frame) - [Eight Ways to Read This Young-Adult Survey](#Eight_Ways_to_Read_This_Young-Adult_Survey)[Frequency Is a Reason to Check In](#Frequency_Is_a_Reason_to_Check_In) - [A Screening Signal, Not a Causal Estimate](#A_Screening_Signal_Not_a_Causal_Estimate) - [Odds Describe Groups, Not Individual Destiny](#Odds_Describe_Groups_Not_Individual_Destiny) - [The Direction of the Relationship Is Unresolved](#The_Direction_of_the_Relationship_Is_Unresolved) - [The Survey Points Beyond Cannabis Alone](#The_Survey_Points_Beyond_Cannabis_Alone) - [Awareness Alone May Not Change Use](#Awareness_Alone_May_Not_Change_Use) - [Young Adults Need Specific Surveillance](#Young_Adults_Need_Specific_Surveillance) - [The Next Step Is Time-Ordered Evidence](#The_Next_Step_Is_Time-Ordered_Evidence) - [Frequently Asked Questions](#Frequently_Asked_Questions)[Related](#Related) ## How to Interpret This Non-Medical Cannabis Use And Self-Reported Mental Health Among Canadian Adults Aged 20 To 24 Evidence Without Overstating It A useful evidence report should let the signal breathe without inflating it. The right question is not whether the paper is positive or negative, but what kind of decision it can responsibly support. ### A Four-Step Reading Frame **Evidence type**Start by identifying whether the paper is a randomized trial, review, meta-analysis, observational study, or protocol. **Population**Ask whether the studied population matches the patient or clinical scenario involving young-adult cannabis use and mental health. **Outcome meaning**Look at what actually changed, how it was measured, and whether the change would matter in daily life. **Safety and uncertainty**Read limitations and adverse effects as part of the result, not as a footnote. The Research Question What does the current evidence suggest about non-medical cannabis use and self-reported mental health among Canadian adults aged 20 to 24? The Patient Question Does this mean I should use cannabinoids for young-adult cannabis use and mental health? The Bottom Line The evidence can inform a careful conversation, but it does not replace individualized clinical care. CED Perspective Lens ## Eight Ways to Read This Young-Adult Survey Clinical, methodological, social, and public-health perspectives Lens OverviewEach viewpoint stays within the verified abstract and separates the observed association from causal or individual-level claims. #### Frequency Is a Reason to Check In For a young adult, the study’s most practical signal is not that any cannabis use predicts a mental-health problem. It is that respondents reporting more frequent non-medical use also reported poorer mental health more often, with the largest odds ratio in the daily or almost daily group. A personal review should ask what is being used, how often, why, and what changes are noticed in mood, anxiety, sleep, cognition, motivation, or functioning. The survey cannot diagnose an individual or determine what caused a symptom, so its value is in prompting a careful conversation rather than producing a verdict. Lens takeawayUse frequency as a prompt for an individualized, nonjudgmental mental-health conversation. #### A Screening Signal, Not a Causal Estimate The reported odds ratios rise from past-year to past-month to daily or almost daily non-medical cannabis use. That pattern can help identify when a broader mental-health and substance-use assessment may be clinically useful, especially when patients report distress or functional change. The design remains cross-sectional, and the outcome is self-reported mental health. Clinicians should avoid translating the association into a causal diagnosis. A useful assessment can document timing, frequency, product type when known, co-use, patient goals, perceived benefits, unwanted effects, and whether symptoms preceded or followed changes in use. Lens takeawayLet the association improve screening depth without overstating direction or causality. #### Odds Describe Groups, Not Individual Destiny An odds ratio compares the odds of an outcome across groups in the analyzed model. The abstract reports OR 1.54 for past-year use, 1.69 for past-month use, and 2.01 for daily or almost daily use, each with a confidence interval above 1. These values do not mean that a specific person’s mental health is a fixed percentage worse, nor do they directly report absolute risk. The accessible abstract does not provide every model detail needed for deeper appraisal. Interpretation should remain at the level the source supports: a graded association in this survey sample. Lens takeawayRead the odds ratios as population associations, not individual predictions or causal effects. #### The Direction of the Relationship Is Unresolved Cannabis use could precede poorer mental health, mental-health difficulties could contribute to cannabis use, or shared social and personal factors could influence both. A cross-sectional analysis measures relationships at one observational point and cannot establish the temporal sequence needed for a causal conclusion. That uncertainty does not make the finding meaningless. It defines what the finding can do: identify a clinically relevant association and motivate longitudinal research. It also defines what the finding cannot do: prove that cannabis produced the reported mental-health status or that changing use alone would change the outcome. Lens takeawayKeep cause and direction open until longitudinal or interventional evidence can test them. #### The Survey Points Beyond Cannabis Alone The abstract reports that heterosexual respondents, those with higher income or education, and residents of Quebec had lower odds of poorer mental health. These findings place the cannabis association inside a wider socioenvironmental pattern rather than presenting use as the only relevant variable. The abstract does not provide enough detail to explain why those differences appeared, and this report does not invent a mechanism. Clinically, the safer lesson is to ask about stressors, supports, identity, finances, education, geography, and access to care alongside substance use. Context can shape both exposure and health. Lens takeawayAssess cannabis use within the person’s broader social and environmental circumstances. #### Awareness Alone May Not Change Use Most respondents, 79 percent, believed that daily or near-daily cannabis use raises mental-health risk. At the same time, nearly half reported past-year non-medical use. The survey therefore shows that general risk recognition and personal behavior can coexist in the same population. Harm-reduction conversations can start with the patient’s own goals and observations rather than repeating a warning they may already know. The study does not test a particular intervention, so it cannot tell clinicians which counseling method works best. It supports respectful discussion of frequency, context, effects, and readiness for change. Lens takeawayPair clear risk information with curiosity about goals, context, and lived experience. #### Young Adults Need Specific Surveillance Adults aged 20 to 24 are often grouped into broader adult categories, but this analysis focuses on a transitional life stage. The prevalence and frequency findings can help public-health teams decide which questions deserve continued monitoring in young-adult populations after legalization. The study does not evaluate a policy change or compare legal regimes, so it should not be used as proof that a particular cannabis law caused the reported pattern. Its contribution is descriptive and associational. Repeated surveys and longitudinal designs would be better suited to tracking trends and testing policy-related explanations. Lens takeawayUse this snapshot to guide surveillance questions, not to claim a policy caused the association. #### The Next Step Is Time-Ordered Evidence Future research should follow young adults over time to clarify whether changes in cannabis-use frequency precede changes in mental health, whether mental-health changes precede use, or whether both move with other factors. Repeated measurement would help establish sequence more clearly than a single cross-sectional analysis. Studies could also report absolute risks and examine product, route, potency, reason for use, co-use, and clinically defined outcomes when those data are available. This article’s accessible abstract does not resolve those questions. Naming them as future needs keeps the current association useful without pretending the evidence is complete. Lens takeawayPrioritize longitudinal, clinically detailed studies that can clarify timing, context, and direction. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion](https://cedclinic.com/interact/discussion-forums/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Share this Evidence Watch [X](https://twitter.com/intent/tweet?text=Cannabis+Use+and+Mental+Health+in+Young+Canadian+Adults%3A+What+a+New+Survey+Found&url=https%3A%2F%2Fcedclinic.com%2Fcanadian-young-adults-cannabis-mental-health-survey%2F) [LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcanadian-young-adults-cannabis-mental-health-survey%2F) [BlueSky](https://bsky.app/intent/compose?text=Cannabis+Use+and+Mental+Health+in+Young+Canadian+Adults%3A+What+a+New+Survey+Found%20https%3A%2F%2Fcedclinic.com%2Fcanadian-young-adults-cannabis-mental-health-survey%2F) [Instagram](https://www.instagram.com/drcaplan/) [Substack](https://doctorapprovedcannabis.substack.com/) [RSS](https://cedclinic.com/feed/) Source: [A Cross-Sectional Analysis of Cannabis Use and Mental Health in Canada’s Young Adults: Canadian Cannabis Survey](https://doi.org/10.1177/21676968261486895) Related Reading at CED ClinicContinue exploring the evidence[What Happens After Cannabis Laws Change? A Review of 176 Policy Studies](https://cedclinic.com/cannabis-policy-substance-use-systematic-review/) Earlier CED coverage of how cannabis-policy changes relate to substance-use outcomes across populations. [Read policy context](https://cedclinic.com/cannabis-policy-substance-use-systematic-review/)[Cannabis for Mental Health in Older Adults: Canadian Survey 2025](https://cedclinic.com/cannabis-mental-health-older-adults-survey-2025/) Canadian survey context from an older population, useful for comparing age-specific evidence boundaries. [Compare age groups](https://cedclinic.com/cannabis-mental-health-older-adults-survey-2025/)[Medical vs. Recreational Cannabis Use: Survey Reveals Overlap](https://cedclinic.com/cannabis-use-psychiatric-symptoms-overlap-survey/) Related survey evidence on cannabis-use patterns and psychiatric symptom overlap. [Review related evidence](https://cedclinic.com/cannabis-use-psychiatric-symptoms-overlap-survey/) Similar Studies on CEDClinic.comEarlier coverage on closely related evidence When a new paper overlaps with earlier CED Clinic coverage, we preserve the chain instead of hiding the overlap. These links point to older related posts so readers can compare what is new, what is repeated, and how the evidence has moved. Related digest item [What Happens After Cannabis Laws Change? A Review of 176 Policy Studies](https://cedclinic.com/cannabis-policy-substance-use-systematic-review/) Cannabis policy and substance use evidence from 176 quasi-experimental reports shows adult cannabis use often rises after liberalization. Alcohol, tobacco, opioid, and youth outcomes varied by policy and population. The… Covers a closely related topic; this CED post is older by about 39 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/cannabis-policy-substance-use-systematic-review/) Related digest item [Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.](https://cedclinic.com/perceptions-marijuana-harmfulness-adults-oregon/) Understanding perceptions of marijuana harmfulness among adults in Oregon is vital for clinicians. These perceptions influence substance use assessments and counseling. This study highlights gaps between public beliefs… Covers a closely related topic; this CED post is older by about 135 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/perceptions-marijuana-harmfulness-adults-oregon/) Related digest item [Cannabis for Mental Health in Older Adults: Canadian Survey 2025](https://cedclinic.com/cannabis-mental-health-older-adults-survey-2025/) A 2025 survey of older Canadians reveals insights on cannabis mental health older adults use, showing most find it helpful but many report adverse effects. The study highlights a perception-safety gap with 62% experienc… Covers a closely related topic; this CED post is older by about 136 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/cannabis-mental-health-older-adults-survey-2025/) Related digest item [Cannabis Side Effects in Older Adults: Canadian Survey Results](https://cedclinic.com/cannabis-adverse-effects-older-adults-canada-survey-2025/) A 2025 Canadian survey reveals cannabis adverse effects older adults commonly experience, including dry mouth and balance issues. The study highlights higher risks for women and younger seniors. These findings emphasize… Covers a closely related topic; this CED post is older by about 136 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/cannabis-adverse-effects-older-adults-canada-survey-2025/) Related digest item [Cannabis Legalization and Pediatric Poisonings: A Global Health Perspective](https://cedclinic.com/cannabis-legalization-pediatric-poisonings-global-health/) Cannabis legalization pediatric poisonings have risen in multiple regions, highlighting a critical public health concern. This review surveys global evidence on pediatric emergency visits and safety challenges. Understa… Covers a closely related topic; this CED post is older by about 136 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/cannabis-legalization-pediatric-poisonings-global-health/) Related digest item [Medical vs. Recreational Cannabis Use: Survey Reveals Overlap](https://cedclinic.com/cannabis-use-psychiatric-symptoms-overlap-survey/) A survey of cannabis users reveals significant cannabis use psychiatric symptoms overlap between medical and recreational users. Most medical users also use recreationally, with higher daily use and psychiatric symptom… Covers a closely related topic; this CED post is older by about 136 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/cannabis-use-psychiatric-symptoms-overlap-survey/) Related digest item [DMT, Cannabis Dementia Risk, Valbenazine Elderly: 2025 Evidence](https://cedclinic.com/cannabis-dementia-risk-older-adults-2025-review/) This 2025 review highlights cannabis dementia risk older adults alongside vaporized DMT for depression and valbenazine treatment in elderly patients. The cannabis dementia risk older adults study shows a higher dementia… Covers a closely related topic; this CED post is older by about 136 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/cannabis-dementia-risk-older-adults-2025-review/) Related digest item [Medical Cannabis Authorization Linked to Modestly Higher Heart Failure Risk in Large Ontario Study](https://cedclinic.com/medical-cannabis-cardiovascular-safety-heart-failure-risk/) This Ontario cohort study examines medical cannabis cardiovascular safety, finding a modestly higher heart failure risk among authorized patients. The hazard ratio was 1.15, indicating a 15% increased risk for heart fai… Covers a closely related topic; this CED post is older by about 141 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/medical-cannabis-cardiovascular-safety-heart-failure-risk/) Related digest item [Who Drank and Used Cannabis More During COVID-19? Income and Identity Both Played a Role](https://cedclinic.com/covid-19-alcohol-cannabis-use-income-race-gender-canada/) This COVID-19 alcohol cannabis use income race gender Canada study reveals how income and identity influenced substance use during the pandemic. It highlights intersectional disparities in drinking and cannabis use. Und… Covers a closely related topic; this CED post is older by about 143 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/covid-19-alcohol-cannabis-use-income-race-gender-canada/) Related digest item [Older Adults Prescribed Cannabis in UK Show Self-Reported Well-Being Gains, But Study Design Cannot Confirm Treatment Caused Improvement](https://cedclinic.com/older-adults-cannabis-registry-study-uk-findings/) The older adults cannabis registry study from the UK shows self-reported well-being improvements after prescribed cannabis use. However, the study design lacks a control group, so treatment effects cannot be confirmed…. Covers a closely related topic; this CED post is older by about 164 days and gives earlier context. [Compare earlier coverage](https://cedclinic.com/older-adults-cannabis-registry-study-uk-findings/) ## Frequently Asked Questions What did the Canadian study examine? It examined non-medical cannabis use and self-reported mental health among 1,240 Canadian adults aged 20 to 24 using 2024 survey data. How common was past-year non-medical cannabis use? Forty-eight percent of respondents reported non-medical cannabis use during the previous 12 months. What did respondents believe about frequent cannabis use? Seventy-nine percent believed that daily or near-daily cannabis use increases the risk of mental-health problems. How many respondents reported favourable mental health? Sixty-two percent reported favourable mental health. What was the association for past-year use? Past-year non-medical use was associated with greater odds of poorer mental health, with an odds ratio of 1.54 and a 95% confidence interval from 1.21 to 1.96. What was the association for daily or almost daily use? Daily or almost daily non-medical use was associated with an odds ratio of 2.01 for poorer mental health, with a 95% confidence interval from 1.42 to 2.85. Does the study prove that cannabis caused poorer mental health? No. The cross-sectional design identifies association but cannot establish cause, direction, or which factor came first. Can the results diagnose an individual patient? No. Population survey results cannot diagnose a person or predict an individual outcome. What is a practical clinical use of the study? The findings can support nonjudgmental questions about cannabis frequency, reasons for use, perceived effects, mental health, and daily functioning. Was the full article available for this review? The peer-reviewed abstract and registered journal metadata were reviewed, but the full article could not be retrieved. This report therefore omits unreported methods, mechanisms, and subgroup details. ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).